XERESE Trademark

Trademark Overview

On Monday, January 25, 2010, a trademark application was filed for XERESE with the United States Patent and Trademark Office. The USPTO has given the XERESE trademark a serial number of 77918965. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, March 15, 2021. This trademark is owned by Medivir AB. The XERESE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-inflammatory and antiviral preparations for topical treatment of cold sores
xerese

General Information

Serial Number77918965
Word MarkXERESE
Filing DateMonday, January 25, 2010
Status800 - REGISTERED AND RENEWED
Status DateMonday, March 15, 2021
Registration Number3975430
Registration DateTuesday, June 7, 2011
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-inflammatory and antiviral preparations for topical treatment of cold sores

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 29, 2010
Primary Code005
First Use Anywhere DateTuesday, March 1, 2011
First Use In Commerce DateTuesday, March 1, 2011

Trademark Owner History

Party NameMEDA PHARMA S. A.R.L.
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressLUXEMBOURG L-2314
LU
Party NameMedivir AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHuddinge 14122
SE
Party NameMedivir AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHuddinge 14122
SE
Party NameMedivir AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHuddinge 14122
SE

Trademark Events

Event DateEvent Description
Friday, April 23, 2010ASSIGNED TO EXAMINER
Friday, April 30, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 11, 2010ASSIGNED TO LIE
Thursday, January 28, 2010NEW APPLICATION ENTERED
Friday, January 29, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 21, 2011TEAS STATEMENT OF USE RECEIVED
Monday, March 21, 2011USE AMENDMENT FILED
Tuesday, March 29, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 30, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 26, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 11, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 15, 2010PUBLISHED FOR OPPOSITION
Tuesday, June 15, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 3, 2011SOU TEAS EXTENSION RECEIVED
Thursday, February 3, 2011SOU EXTENSION 1 FILED
Thursday, February 3, 2011SOU EXTENSION 1 GRANTED
Saturday, February 5, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, April 30, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, May 3, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 7, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, January 18, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 5, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 1, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 1, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 12, 2017TEAS SECTION 8 & 15 RECEIVED
Saturday, July 8, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, June 7, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 7, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 6, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 12, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 8, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 8, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 3, 2020TEAS SECTION 8 & 9 RECEIVED
Monday, March 15, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 15, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, March 15, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, June 24, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 24, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 15, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

xerese preparations treatment cold sores topical inflammatory namely anti pharmaceutical antiviral